School of Nursing and Midwifery, Western Sydney University, Penrith, New South Wales, Australia.
Emergency Department, Westmead Hospital, Sydney, New South Wales, Australia.
Emerg Med Australas. 2022 Jun;34(3):361-369. doi: 10.1111/1742-6723.13893. Epub 2021 Nov 12.
To investigate the association between timing and volume of intravenous fluids administered to ED patients with suspected infection and all-cause in-hospital mortality.
Retrospective cohort study of ED presentations at four metropolitan hospitals in Sydney, Australia, between October 2018 and May 2019. Patients over 16 years of age with suspected infection who received intravenous fluids within 24 h of presentation were included.
During the study period, 7533 patients with suspected infection received intravenous fluids. Of these, 1996 (26.5%) and 231 (3.1%) had suspected sepsis and septic shock, respectively. Each 1000 mL increase in intravenous fluids administered was associated with a reduction in risk of in-hospital mortality (adjusted odds ratio [AOR] 0.87, 95% confidence interval [CI] 0.76-0.99). This association was stronger in patients with septic shock (AOR 0.66, 95% CI 0.49-0.89), and those admitted to intensive care unit (ICU) (AOR 0.74, 95% CI 0.56-0.96). Patients with suspected sepsis and septic shock who received a total volume of >3600 mL had lower in-hospital mortality (AOR 0.44, 95% CI 0.22-0.91; AOR 0.16, 95% CI 0.05-0.57) compared to those administered <3600 mL within the first 24 h of presenting to the ED. There was no association between the time of initiation of fluids and in-hospital mortality among survivors and non-survivors (2.3 vs 2.5 h, P = 0.50).
We observed a reduction in risk of in-hospital mortality for each 1000 mL increase in intravenous fluids administered in patients with septic shock or admitted to ICU suggesting illness severity to be a likely effect modifier.
探讨急诊科疑似感染患者静脉输液的时间和容量与全因住院死亡率之间的关系。
这是一项在澳大利亚悉尼四家都市医院急诊科就诊的患者中进行的回顾性队列研究,研究时间为 2018 年 10 月至 2019 年 5 月。纳入年龄超过 16 岁、在就诊后 24 小时内接受静脉输液且疑似感染的患者。
在研究期间,7533 例疑似感染患者接受了静脉输液。其中,1996 例(26.5%)和 231 例(3.1%)分别患有疑似脓毒症和感染性休克。静脉输液量每增加 1000ml,住院死亡率降低(校正优势比[OR]0.87,95%置信区间[CI]0.76-0.99)。这种关联在感染性休克患者(OR 0.66,95%CI 0.49-0.89)和入住重症监护病房(ICU)的患者(OR 0.74,95%CI 0.56-0.96)中更强。与在急诊科就诊的前 24 小时内接受<3600ml 总容量的患者相比,疑似脓毒症和感染性休克患者接受>3600ml 总容量的患者的住院死亡率更低(OR 0.44,95%CI 0.22-0.91;OR 0.16,95%CI 0.05-0.57)。在幸存者和非幸存者中,液体开始时间与住院死亡率之间没有关联(2.3 小时与 2.5 小时,P=0.50)。
我们观察到感染性休克或入住 ICU 的患者每增加 1000ml 静脉输液,住院死亡率降低,这表明疾病严重程度可能是一个重要的影响因素。